1. Home
  2. ATXS vs CMP Comparison

ATXS vs CMP Comparison

Compare ATXS & CMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATXS
  • CMP
  • Stock Information
  • Founded
  • ATXS 2008
  • CMP 1993
  • Country
  • ATXS United States
  • CMP United States
  • Employees
  • ATXS N/A
  • CMP N/A
  • Industry
  • ATXS Biotechnology: Pharmaceutical Preparations
  • CMP Other Metals and Minerals
  • Sector
  • ATXS Health Care
  • CMP Basic Materials
  • Exchange
  • ATXS Nasdaq
  • CMP Nasdaq
  • Market Cap
  • ATXS 676.1M
  • CMP 781.2M
  • IPO Year
  • ATXS 2015
  • CMP 2003
  • Fundamental
  • Price
  • ATXS $12.46
  • CMP $18.73
  • Analyst Decision
  • ATXS Buy
  • CMP Hold
  • Analyst Count
  • ATXS 7
  • CMP 3
  • Target Price
  • ATXS $30.00
  • CMP $20.00
  • AVG Volume (30 Days)
  • ATXS 4.1M
  • CMP 383.2K
  • Earning Date
  • ATXS 11-12-2025
  • CMP 12-15-2025
  • Dividend Yield
  • ATXS N/A
  • CMP N/A
  • EPS Growth
  • ATXS N/A
  • CMP N/A
  • EPS
  • ATXS N/A
  • CMP N/A
  • Revenue
  • ATXS N/A
  • CMP $1,225,200,000.00
  • Revenue This Year
  • ATXS N/A
  • CMP $12.05
  • Revenue Next Year
  • ATXS N/A
  • CMP $4.15
  • P/E Ratio
  • ATXS N/A
  • CMP N/A
  • Revenue Growth
  • ATXS N/A
  • CMP 7.27
  • 52 Week Low
  • ATXS $3.56
  • CMP $8.60
  • 52 Week High
  • ATXS $12.55
  • CMP $22.69
  • Technical
  • Relative Strength Index (RSI)
  • ATXS 84.72
  • CMP 49.61
  • Support Level
  • ATXS $11.83
  • CMP $17.54
  • Resistance Level
  • ATXS $12.16
  • CMP $18.68
  • Average True Range (ATR)
  • ATXS 0.36
  • CMP 0.87
  • MACD
  • ATXS 0.26
  • CMP -0.06
  • Stochastic Oscillator
  • ATXS 97.97
  • CMP 44.20

About ATXS Astria Therapeutics Inc.

Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema. Their second product candidate is STAR-0310, a monoclonal antibody OX40 antagonist that is in preclinical development for the treatment of atopic dermatitis, or AD, an immune disorder associated with loss of skin barrier function and itching.

About CMP Compass Minerals Intl Inc

Compass Minerals currently produces two primary products: salt and specialty potash fertilizer. The company's main assets include rock salt mines in Ontario, Louisiana, and the United Kingdom. The fertilizer is produced from a brine operation at the Great Salt Lake in Utah that produces sulfate of potash and magnesium chloride. Compass' salt products are used for deicing and also by industrial and consumer end markets. The firm's sulfate of potash is used by growers of high-value crops that are sensitive to standard potash.

Share on Social Networks: